Blood Reviews
Volume 23, Issue 6 , Pages 245-255 , November 2009

Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions

  • Christopher C. Silliman

      Affiliations

    • Bonfils Blood Center, Denver CO, USA
    • The Department of Pediatrics, University of Colorado Denver, Aurora, CO, USA
    • Surgery, University of Colorado Denver, Aurora, CO, USA
    • Corresponding Author InformationCorresponding author. Address: Research Department, Bonfils Blood Center, 717 Yosemite Street, Denver, CO 80230, USA. Tel.: +1 303 363 2246; fax: +1 303 340 2616.
    • ,
  • Yoke Lin Fung

      Affiliations

    • Australian Red Cross Blood Service, Brisbane, Queensland, Australia
    • ,
  • J. Bradley Ball

      Affiliations

    • Bonfils Blood Center, Denver CO, USA
    • The Department of Pediatrics, University of Colorado Denver, Aurora, CO, USA
    • ,
  • Samina Y. Khan

      Affiliations

    • Bonfils Blood Center, Denver CO, USA
    • The Department of Pediatrics, University of Colorado Denver, Aurora, CO, USA

References 

  1. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6):573–577
  2. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774–1789
  3. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33(4):721–726
  4. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997;37(7):719–726
  5. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2):454–462
  6. Covin RB, Ambruso DR, England KM, Kelher MR, Mehdizadehkashi Z, Boshkov LK, et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus Med. 2004;14(5):375–383
  7. Popovsky MA. Transfusion related acute lung injury. In:  Popovsky MA editors. Transfusion reactions. 2nd ed.. Bethesda, MD: AABB Press; 2001;
  8. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care. 1994;9(1):72–81
  9. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev. 1999;13(3):177–186
  10. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma. 2006;60(6 Suppl.):S46–S50
  11. Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?. Transfus Med. 2001;11(6):403–417
  12. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007;131(5):1308–1314
  13. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet. 2001;357(9273):2023–2024
  14. Power CA, Clemetson JM, Clemetson KJ, Wells TN. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine. 1995;7(6):479–482
  15. Schroder JM, Kameyoshi Y, Christophers E. RANTES, a novel eosinophil-chemotactic cytokine. Ann N Y Acad Sci. 1994;725(May 28):91–103
  16. Wakamoto S, Fujihara M, Kuzuma K, Sato S, Kato T, Naohara T, et al. Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion. 2003;43(8):1038–1046
  17. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41(10):1244–1248
  18. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287(15):1968–1971
  19. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2008;(October 28):
  20. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion. 2003;43(8):1053–1059
  21. Wallis JP. Transfusion-related acute lung injury (TRALI)–under-diagnosed and under-reported. Br J Anaesth. 2003;90(5):573–576
  22. Renaudier PC, Vo Mai MP, Azanowsky JM, Breton P, Cheze S, Girard A, et al. Epidemiology of transfusion related acute lung injury in Gifit, the Frech Hemovigilance Database: a study of the French Hemovigilance Network. Transfusion. 2004;44(9S):23A;[Ref Type: Abstract]
  23. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, et al. Transfusion related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med. 2007;(July 12):
  24. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98(5 Pt 1):593–597
  25. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion. 2003;43(2):185–191
  26. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med. 1995;332(1):27–37
  27. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144(1):124–130
  28. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101(7):1458–1467
  29. Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ. The pathology of transfusion-related acute lung injury. Am J Clin Pathol. 1999;112(2):216–221
  30. Chaiwat O, Lang JD, Vavilala MS, Wang J, MacKenzie EJ, Jurkovich GJ, et al. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology. 2009;110(2):351–360
  31. Silverboard H, Aisiku I, Martin GS, Adams M, Rozycki G, Moss M. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma. 2005;59(3):717–723
  32. Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, et al. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care. 2007;11(3):R63
  33. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89(1):1–10
  34. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004;126(1):249–258
  35. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116(6):1615–1623
  36. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105(6):2266–2273
  37. Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion. 2005;45(2 Suppl.):109S–116S
  38. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev. 2006;20(3):139–159
  39. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med. 2006;34(5 Suppl.):S124–S131
  40. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504–512
  41. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84(7):2068–2101
  42. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil- endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis. 1998;177(6):1465–1474
  43. Vedder NB, Harlan JM. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest. 1988;81(3):676–682
  44. Wyman TH, Bjornsen AJ, Elzi DJ, Smith CW, England KM, Kelher M, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283(6):C1592–C1603
  45. Cinat ME, Waxman K, Granger GA, Pearce W, Annas C, Daughters K. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg. 1994;179(5):529–537
  46. Li S, Jiao X, Tao L, Liu H, Cao Y, Lopez BL, et al. Tumor necrosis factor-{alpha} in mechanic trauma plasma mediates cardiomyocyte apoptosis. Am J Physiol Heart Circ Physiol. 2007;293(3):H1847–H1852
  47. Maier B, Lefering R, Lehnert M, Laurer HL, Steudel WI, Neugebauer EA, et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007 July 19; Publish Ahead of Print.
  48. Tan PH, Xue SA, Manunta M, Beutelspacher SC, Fazekasova H, Alam AK, et al. Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol. 2006;26(3):462–467
  49. Burns JA, Issekutz TB, Yagita H, Issekutz AC. The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation. J Immunol. 2001;166(7):4644–4649
  50. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation. 2001;8(2):71–88
  51. Downey GP, Worthen GS. Neutrophil retention in model capillaries: deformability, geometry, and hydrodynamic forces. J Appl Physiol. 1988;65(4):1861–1871
  52. Downey GP, Doherty DE, Schwab B, Elson EL, Henson PM, Worthen GS. Retention of leukocytes in capillaries: role of cell size and deformability. J Appl Physiol. 1990;69(5):1767–1778
  53. Downey GP, Worthen GS, Henson PM, Hyde DM. Neutrophil sequestration and migration in localized pulmonary inflammation. Capillary localization and migration across the interalveolar septum. Am Rev Respir Dis. 1993;147(1):168–176
  54. Lien DC, Henson PM, Capen RL, Henson JE, Hanson WL, Wagner WW, et al. Neutrophil kinetics in the pulmonary microcirculation during acute inflammation. Lab Invest. 1991;65(2):145–159
  55. Worthen GS, Schwab B, Elson EL, Downey GP. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science. 1989;245(4914):183–186
  56. Gans RO, Duurkens VA, van Zundert AA, Hoorntje SJ. Transfusion-related acute lung injury. Intensive Care Med. 1988;14(6):654–657
  57. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte- specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion. 1990;30(1):42–45
  58. Yomtovian R, Kline W, Press C, Clay M, Engman H, Hammerschmidt D, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet. 1984;1(8371):244–246
  59. Boshkov LK. Transfusion-associated acute lung injury (TRALI): an evolving understanding of the role of anti-leukocyte antibodies. Vox Sang. 2002;83(Suppl. 1):299–303
  60. Popovsky MA, Chaplin HC, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion. 1992;32(6):589–592
  61. Popovsky MA. Transfusion-related acute lung injury. In:  Popovsky MA editors. Transfusion reactions. 1st ed.. Bethesda, MD: American Association of Blood Banks Press; 1996;p. 167–183
  62. Seeger W, Schneider U, Kreusler B, von Witzleben E, Walmrath D, Grimminger F, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76(7):1438–1444
  63. Brittingham TE, Chaplin H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. J Am Med Assoc. 1957;165(7):819–825
  64. Dooren MC, Ouwehand WH, Verhoeven AJ, von dem Borne AE, Kuijpers RW. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet. 1998;352(9140):1601–1602
  65. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384–391
  66. Sachs UJ, Hattar K, Weissmann N, Bohle RM, Weiss T, Sibelius U, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. 2006;107(3):1217–1219
  67. Partrick DA, Moore EE, Fullerton DA, Barnett CC, Meldrum DR, Silliman CC. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res. 1999;86(1):42–49
  68. Ward RA, McLeish KR. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs. 1995;19(8):801–807
  69. Kelher MR, Masuno T, Moore EE, Damle S, Meng X, Song Y, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood. 2009;113(9):2079–2087
  70. Wallis JP, Haynes S, Stark G, Green FA, Lucas GF, Chapman CE. Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion. Lancet. 2002;360(9339):1073–1074
  71. Varela M, Mas A, Nogues N, Escorsell A, Mazzara R, Lozano M. TRALI associated with HLA class II antibodies. Transfusion. 2002;42(8):1102
  72. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies. Transfusion. 2003;43(4):545–546
  73. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, et al. Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007;47(4):599–607
  74. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43(2):177–184
  75. Sakagawa H, Miyazaki T, Fujihara M, Sato S, Yamaguchi M, Fukai K, et al. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions. Transfusion. 2007;47(1):154–161
  76. Nishimura M, Hashimoto S, Satake M, Okazaki H, Tadokoro K. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR. Vox Sang. 2007;93(1):78–82
  77. Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med. 2007;17(2):129–134
  78. Gronert K, Clish CB, Romano M, Serhan CN. Transcellular regulation of eicosanoid biosynthesis. Methods Mol Biol. 1999;120:119–144
  79. Krump E, Picard S, Mancini J, Borgeat P. Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. J Exp Med. 1997;186(8):1401–1406
  80. Palmantier R, Rocheleau H, Laviolette M, Mancini J, Borgeat P. Characteristics of leukotriene biosynthesis by human granulocytes in presence of plasma. Biochim Biophys Acta. 1998;1389(3):187–196
  81. Sala A, Bolla M, Zarini S, Muller-Peddinghaus R, Folco G. Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes. J Biol Chem. 1996;271(30):17944–17948
  82. Serhan CN. Cell-cell interactions in the generation of eicosanoids: charting the routes and products of transcellular biosynthesis. J Lab Clin Med. 1993;121(3):372–374
  83. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 1993;151(3):1482–1490
  84. Lei L, Altstaedt J, von der OM, Proft T, Gross U, Rink L. Induction of interleukin-8 in human neutrophils after MHC class II cross-linking with superantigens. J Leukoc Biol. 2001;70(1):80–86
  85. Matsumoto S, Takei M, Moriyama M, Imanishi H. Enhancement of Ia-like antigen expression by interferon-gamma in polymorphonuclear leukocytes. Chem Pharm Bull (Tokyo). 1987;35(1):436–439
  86. Reinisch W, Lichtenberger C, Steger G, Tillinger W, Scheiner O, Gangl A, et al. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol. 2003;133(3):476–484
  87. Spagnoli GC, Juretic A, Rosso R, Van BJ, Harder F, Heberer M. Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Hum Immunol. 1995;43(1):45–50
  88. Zarco MA, Ribera JM, Villamor N, Balmes A, Urbano IA, Feliu E. Phenotypic changes in neutrophil granulocytes after G-CSF administration in patients with acute lymphoblastic leukemia under chemotherapy. Haematologica. 1998;83(6):573–575
  89. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion. 2004;44(12):1683–1688
  90. Aysola AE, Deisting B, Mair DC. Review of 16 blood components from a donor with HLA class II antibodies. Transfusion. 2005;45(Suppl.):83A;[Ref Type: Abstract]
  91. Maslanka K, Michur H, Zupanska B, Uhrynowska M, Nowak J. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang. 2007;92(3):247–249
  92. Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sang. 2007;93(1):70–77
  93. Silliman CC, Kelher M, Hess JR, England KM, Gorman J, McLaughlin-Malaxecheberria N, et al. Experimental additive solution-64 inhibits the accumulation of neutrophil priming activity and interleukin-18 during storage of packed red blood cells. Blood. 2002;100(Suppl.):[Ref Type: Abstract]
  94. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124(5):684–694
  95. Silliman CC, Dickey WO, Paterson AJ, Thurman GW, Clay KL, Johnson CA, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996;36(2):133–139
  96. Silliman CC, Elzi DJ, Ambruso DR, Musters RJ, Hamiel C, Harbeck RJ, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol. 2003;73(4):511–524
  97. Aiboshi J, Moore EE, Ciesla DJ, Silliman CC. Blood transfusion and the two-insult model of post-injury multiple organ failure. Shock. 2001;15(4):302–306
  98. Silliman CC, Bjornsen AJ, Wyman TH, Kelher M, Allard J, Bieber S, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43(5):633–640
  99. Arnold R, Konig W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol. 2005;174(11):7359–7367
  100. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol. 2004;85(Pt 7):1801–1813
  101. Vilela MC, Mansur DS, Lacerda-Queiroz N, Rodrigues DH, Arantes RM, Kroon EG, et al. Traffic of leukocytes in the central nervous system is associated with chemokine up-regulation in a severe model of herpes simplex encephalitis: an intravital microscopy study. Neurosci Lett. 2008;445(1):18–22
  102. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18(3):184–188
  103. Keifer JC, Kingsley CP, Roth MT, Abt AB, Romano PJ. Transfusion-related acute lung injury (TRALI) complicating colectomy for ulcerative colitis. Anesthesiology. 1998;89(4):1020–1023
  104. Medeiros BC, Kogel KE, Kane MA. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apheresis Sci. 2003;29(1):25–27
  105. Roffey P, Thangathurai D, Mikhail M, Riad M, Mogos M. TRALI and massive transfusion. Resuscitation. 2003;58(1):121
  106. Han I, Saito H, Fukatsu K, Inoue T, Yasuhara H, Furukawa S, et al. Ex vivo fluorescence microscopy provides simple and accurate assessment of neutrophil-endothelial adhesion in the rat lung. Shock. 2001;16(2):143–147
  107. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest. 1990;85(4):1135–1143
  108. Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol. 1999;66(1):10–24
  109. Woodman RC, Teoh D, Payne D, Kubes P. Thrombin and leukocyte recruitment in endotoxemia. Am J Physiol Heart Circ Physiol. 2000;279(3):H1338–H1345
  110. Abraham E. Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc. 2005;2(3):243–247
  111. O’Brien JM, Abraham E. Human models of endotoxemia and recombinant human activated protein C. Crit Care Med. 2004;32(5 Suppl.):S202–S208
  112. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108(7):2455–2462
  113. Bueter M, Thalheimer A, Schuster F, Bock M, von EC, Meyer D, et al. Transfusion-related acute lung injury (TRALI) – an important, severe transfusion-related complication. Langenbecks Arch Surg. 2006;391(5):489–494
  114. Fung YL, Williams BA. TRALI in 2 cases of leukemia. J Pediatr Hematol Oncol. 2006;28(6):391–394
  115. Higgins S, Fowler R, Callum J, Cartotto R. Transfusion-related acute lung injury in patients with burns. J Burn Care Res. 2007;28(1):56–64
  116. Li GS, Ye QF, Xia SS, Chen ZS, Zeng FJ, Lin ZB, et al. Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat Dis Int. 2002;1(3):330–334
  117. Sanchez R, Bacchetti P, Toy P. Transfusion-related acute lung injury: a case-control pilot study of risk factors. Am J Clin Pathol. 2007;128(1):128–134
  118. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007;109(4):1752–1755
  119. Bux J, Stroncek D. Human neutrophil antigens. Transfusion. 2002;42(11):1523
  120. Lucas G, Rogers S, de HM, Porcelijn L, Bux J. Report on the fourth international granulocyte immunology workshop: progress toward quality assessment. Transfusion. 2002;42(4):462–468
  121. Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang. 2008;(December 25):
  122. Bux J. Challenges in the determination of clinically significant granulocyte antibodies and antigens. Transfus Med Rev. 1996;10(3):222–232
  123. Fung YL, Goodison KA, Wong JK, Minchinton RM. Investigating transfusion-related acute lung injury (TRALI). Intern Med J. 2003;33(7):286–290
  124. Lalezari P, Radel E. Neutrophil-specific antigens: immunology and clinical significance. Semin Hematol. 1974;11(3):281–290
  125. Verheugt FW, von dem Borne AE, van Noord-Bokhorst JC, van Elven EH, Engelfriet CP. Serological, immunochemical and immunocytological properties of granulocyte antibodies. Vox Sang. 1978;35(5):294–303
  126. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation. 2008;86(3):384–390
  127. Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res. 2006;36(1–3):255–264
  128. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288(3):315–316
  129. Fadeyi EA, De Los Angeles MM, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion. 2007;47(3):545–550
  130. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;(May 18):
  131. Fadeyi E, Adams S, Peterson B, Hackett J, Byrne P, Klein HG, et al. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors. Transfusion. 2008;48(6):1174–1179
  132. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion. 2008;(August 20):
  133. Sachs UJ, Link E, Hofmann C, Wasel W, Bein G. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience. Transfus Med. 2008;18(6):348–354
  134. Kao KJ, Scornik JC, Riley WJ, McQueen CF. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol. 1988;21(2):115–124
  135. Jensen S, Jersild C, Grunnet N. Severe transfusion reaction to donor plasma containing HLA antibody. Vox Sang. 1990;59(1):62
  136. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105(2):322–329
  137. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion. 2003;43(12):1683–1686
  138. Muniz M, Sheldon S, Schuller RM, Young NS, Klein HG, Leitman SF, et al. Patient-specific transfusion-related acute lung injury. Vox Sang. 2008;94(1):70–73
  139. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med. 2004;14(3):225–230
  140. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996;93(3):707–713
  141. Reil A, Keller-Stanislawski B, Gunay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313–317
  142. Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, et al. Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus Med. 2004;14(2):157–164
  143. Flesland O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med. 2007;33(Suppl. 1):S17–S21
  144. Hume HA. TRALI: moving toward prevention. Transfusion. 2009;49(3):402–405
  145. Middelburg RA, van Stein D, Zupanska B, Uhrynowska M, Gajic O, Silliman CC, et al. Inconsistent association between donor gender and clinically defined TRALI. J Thromb Haenostas. 2008;6;[Ref Type: Abstract]
  146. Boshkov LK, Maloney J, Bieber S, Silliman CC. Two cases of TRALI from the same platelet unit: implications for pathophysiology and the role of PMNs and VEGF. Blood. 2000;96(11):655a;[Ref Type: Abstract]
  147. Kopko PM. Review: transfusion-related acute lung injury: pathophysiology, laboratory investigation, and donor management. Immunohematol. 2004;20(2):103–111
  148. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous?. Transfusion. 2001;41(3):317–322
  149. Gajic O, Yilmaz M, Iscimen R, Kor DJ, Winters JL, Moore SB, et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med. 2007;35(7):1645–1648
  150. Benjamin RJ, Roggeveen B, Reeves C, Kelly ME. TRALI: components from female donors are not disproportionately involved in common transfusion reactions. Transfusion. 2004;44(9S):34A;[Ref Type: Abstract]
  151. Brumit MC, Welsby I, Phillips-Bute B, Ramsey R, Lin S, Boyd T, et al. Relationship between FFP donor gender and outcome in 2, 157 transfused cardiac surgery patients. Transfusion. 2007;47(Suppl.):6A;[Ref Type: Abstract]
  152. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma. 2007;62(1):112–119
  153. Landro L. New roles may shrink banks of blood donors. Wall Street J. 2007;Jan 10;Sect Personal J:D1–8
  154. Neergaard L. Gender matters in plasma transfusion. Associated Press Wire Service; 2007;Jan 22

PII: S0268-960X(09)00044-7

doi: 10.1016/j.blre.2009.07.005

Blood Reviews
Volume 23, Issue 6 , Pages 245-255 , November 2009

Article Tools

* Image Usage & Resolution